SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 11th, 2023 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 7, 2023, between Palisade Bio, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • September 11th, 2023 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • New York
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT palisade bio, inc.Placement Agent Agreement • September 11th, 2023 • Palisade Bio, Inc. • Biological products, (no disgnostic substances)
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September 11, 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September 7, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Palisade Bio, Inc., a Delaware corporation (the “Company”), up to _____ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Placement Agency Agreement, by and between the Company and Ladenburg Thalmann & Co. Inc., dated as of September 7, 2023.
